Effects of Chinese Medicine on Patients With Severe Acute Exacerbation of COPD

Launched by HENAN UNIVERSITY OF TRADITIONAL CHINESE MEDICINE · Jun 7, 2024

Keywords

ClinConnect Summary

This clinical trial is looking at how Chinese medicine can help patients experiencing severe flare-ups of Chronic Obstructive Pulmonary Disease (COPD), a condition that makes it hard to breathe. The goal is to see if combining Chinese medicine with traditional Western treatments can improve care for these patients. The trial is not yet recruiting participants, but it will focus on adults aged 40 to 80 who have been diagnosed with severe acute exacerbations of COPD and meet certain health criteria.

To qualify for the trial, patients must have specific symptoms related to their condition and be willing to participate. However, individuals who are pregnant, have serious heart or lung issues, or certain other health problems will not be eligible. If you join the study, you can expect to receive treatment that may include Chinese medicine alongside standard care, and the researchers hope this will lead to better management of your COPD symptoms. Participating in this trial could contribute to new insights on treating severe COPD effectively.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Patients with severe AECOPD.;
• • 2. Age 40-80 years old;
• • 3. Chinese medicine diagnosis consistent with external cold and internal drink syndrome, or phlegm-heat congestion of the lungs syndrome, or phlegm turbidity obstruction of the lungs syndrome;
• • 4. Voluntarily accept the treatment and sign the informed consent form;
• Exclusion Criteria:
• • 1. Pregnant and lactating women.
• • 2. delirious, dementia, various mental patients and other people who cannot communicate normally.
• • 3. Patients with severe cardiac insufficiency (NYHA grade IV), malignant arrhythmia and hemodynamic instability.
• • 4. Patients with acute respiratory failure who require tracheal intubation or invasive mechanical ventilation.
• • 5. Complicated with bronchiectasis, active tuberculosis, severe liver and kidney disease (severe liver disease refers to cirrhosis, portal hypertension and varicose vein bleeding, etc., serious kidney disease including dialysis, kidney transplantation, etc.), pneumonia, HIV infection or immunosuppressive state, advanced malignant tumor, etc.
• • 6. long-term bedridden patients for various reasons.
• • 7. Out-of-hospital treatment for more than 3 days.
• • 8. Participate in other drug clinical investigators within 1 month before enrollment.
• • 9. Allergic to therapeutic drugs.